FMOD
Basic information
Region (hg38): 1:203340628-203351758
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FMOD gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 34 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 0 | 0 |
Variants in FMOD
This is a list of pathogenic ClinVar variants found in the FMOD region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-203342414-C-G | not specified | Uncertain significance (May 31, 2023) | ||
1-203347295-T-G | not specified | Uncertain significance (Aug 21, 2023) | ||
1-203347379-G-T | not specified | Uncertain significance (Oct 25, 2023) | ||
1-203347436-T-C | not specified | Uncertain significance (Dec 19, 2022) | ||
1-203347450-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
1-203347472-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
1-203347490-C-T | not specified | Uncertain significance (May 20, 2024) | ||
1-203347496-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
1-203347523-A-G | not specified | Uncertain significance (Nov 03, 2022) | ||
1-203347556-G-T | not specified | Uncertain significance (Aug 31, 2022) | ||
1-203347564-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
1-203347595-T-C | not specified | Uncertain significance (Apr 23, 2024) | ||
1-203347604-G-A | not specified | Uncertain significance (May 04, 2023) | ||
1-203347702-C-T | not specified | Uncertain significance (Aug 19, 2023) | ||
1-203347744-C-T | not specified | Uncertain significance (Jun 28, 2023) | ||
1-203347823-C-G | not specified | Uncertain significance (May 02, 2024) | ||
1-203347832-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
1-203347834-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
1-203347854-G-T | not specified | Uncertain significance (Nov 19, 2022) | ||
1-203347859-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
1-203347872-C-G | not specified | Uncertain significance (Jan 16, 2024) | ||
1-203347901-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
1-203347979-T-G | not specified | Uncertain significance (Jun 06, 2023) | ||
1-203348000-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
1-203348030-C-T | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FMOD | protein_coding | protein_coding | ENST00000354955 | 2 | 10862 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00236 | 0.932 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0844 | 228 | 224 | 1.02 | 0.0000140 | 2460 |
Missense in Polyphen | 72 | 79.813 | 0.90211 | 998 | ||
Synonymous | 0.387 | 99 | 104 | 0.952 | 0.00000668 | 776 |
Loss of Function | 1.61 | 6 | 12.0 | 0.499 | 5.85e-7 | 130 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000530 | 0.0000527 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000679 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Affects the rate of fibrils formation. May have a primary role in collagen fibrillogenesis (By similarity). {ECO:0000250}.;
- Pathway
- Metabolism of carbohydrates;Keratan sulfate biosynthesis;Keratan sulfate/keratin metabolism;Glycosaminoglycan metabolism;Extracellular matrix organization;Metabolism;ECM proteoglycans
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.378
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.56
Haploinsufficiency Scores
- pHI
- 0.307
- hipred
- N
- hipred_score
- 0.398
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.752
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fmod
- Phenotype
- skeleton phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; craniofacial phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- transforming growth factor beta receptor complex assembly;keratan sulfate biosynthetic process;collagen fibril organization;keratan sulfate catabolic process
- Cellular component
- extracellular region;extracellular space;Golgi lumen;extracellular matrix;lysosomal lumen;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent conferring compression resistance